Novel technology to detect T cell response in COVID-19 infections

The U.S. Food and Drug Administration recently approved the use of the “T-Detect” COVID Test, developed by Adaptive Biotechnologies, to determine if a person has had a recent or prior SARS-CoV-2 infection.